1 December 2019 in Pancreatology
11 April 2022 in Epigenetics
Pancreatic cancer (PC) is one of the most fatal cancers with a very poor prognosis. Here, we found that N6-methyladenosine (m6A) RNA demethylase fat mass and obesity-related protein (FTO) promote the growth, migration and invasion of PC. FTO expression level is increased in human PC and is associated with poor prognosis of PC patients. Knockdown of FTO increases m6A methylation of TFPI-2 mRNA in PC cells, thereby increasing mRNA stability via the m6A reader YTHDF1, resulting in up-regulation of TFPI-2 expression, and inhibits PC proliferation, colony formation, sphere formation, migration and invasion in vitro, as well as tumour growth in vivo. Rescue assay further confirms that FTO facilitates cancer progression by reducing the expression of TFPI-2. Mechanistically, FTO promotes the progression of PC at least partially through reducing m6A/YTHDF1 mediated TFPI-2 mRNA stability. Our findings reveal that FTO, as an m6A demethylase, plays a critical role in promoting PC growth, migration and invasion, suggesting that FTO may be a potential therapeutic target for treating PC.
25 July 2022 in Cancer Medicine
Pancreatic cancer (PC) is a deadly disease, and its post‐transcriptional gene regulation mechanism remains unclear. The abundant extracellular matrix (ECM) in PC plays an important role in tumor progression. This study is the first to focus on the role of N6‐methyladenosine (m6A) RNA methylation, an emerging post‐transcriptional regulatory mechanism, in the regulation of the ECM in PC. Here, we found that ADAMTS2, COL12A1, and THBS2 were associated with the prognosis of PC by comprehensive analysis of differentially expressed genes from two independent GEO expression profile datasets and m6A‐related genes in RMVar database (PAAD). GO and KEGG enrichment analysis found that these m6A‐related targets are chiefly functionally concentrated in the ECM region and participate in ECM signal transduction. Correlation analysis revealed that these genes can be regulated by the demethylase FTO. Cell biology function assays showed that knockdown of FTO‐inhibited PC cell abilities to migrate and invade in vitro. qRT‐PCR and MeRIP experiments showed that after knockdown of FTO, the mRNA levels of ADAMTS2, COL12A1, and THBS2 and their m6A modification levels were significantly reduced. These results indicate that m6A RNA demethylation is associated with the regulation of ECM in PC. In conclusion, m6A RNA demethylase FTO regulates ECM‐related genes and promotes PC cell abilities to migrate and invade, our work provides a new perspective on the molecular mechanism of PC progression.
4 September 2020 in Experimental and Therapeutic Medicine
Pancreatic carcinoma (PC) is a rapidly progressive, fatal malignant tumor with the poorest prognosis among all major carcinoma types. MicroRNAs (miRNAs/miRs) have been indicated to be key post‑transcriptional regulatory factors, which are involved in cancer development. The present study was designed to investigate the effect of miR‑23a on PC cell proliferation, metastasis and apoptosis. The expression of miR‑23a was detected in a normal pancreatic ductal epithelial cell line and three PC cell lines, and miR‑23a inhibitor or mimics were transfected into the Panc‑1 and MiaPaCa2 PC cells. The association between miR‑23a and tissue factor pathway inhibitor (TFPI)‑2 was examined using a luciferase reporter assay. MTT and flow cytometry assays were used to assess cell viability and apoptosis, respectively. Furthermore, wound‑healing, Transwell and Matrigel assays were used to evaluate cell migration and invasion abilities, and the protein expression level of TFPI‑2 was determined using western blot analysis. The results of the present study revealed that miR‑23a was upregulated in PC cells. Furthermore, TFPI‑2 was identified as a downstream target of miR‑23a, and TFPI‑2 expression was found to be increased following miR‑23a knockdown. In addition, functional assays revealed that downregulation of miR‑23a decreased PC cell proliferation, migration and invasiveness and promoted cell apoptosis, while miR‑23a overexpression exerted the opposite effects. Furthermore, TFPI‑2 knockdown rescued the biological effects on PC cells, which were induced by miR‑23a knockdown. The results of the present study indicated that miR‑23a negatively modulated TFPI‑2 expression in vitro and enhanced the malignant phenotypes of PC cells. Therefore, miR‑23a may be a potential marker and/or target for the diagnosis and treatment of PC.